Statement Of Comprehensive Income [Abstract]

Hyloris Pharmaceuticals SA - Filing #5880974

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Statement of comprehensive income [abstract]
Profit (loss)
6,342,000 EUR
15,380,000 EUR
Other comprehensive income [abstract]
Other comprehensive income
- EUR
- EUR
Comprehensive income
6,342,000 EUR
6,342,000 EUR
15,380,000 EUR
15,380,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.